1.

(b) Name the source used to produce hepatitis B vaccine rDNA technology.

Answer» Recombinant DNA technology has allowed the production of antigenic polypeptides of pathogen in bacteria or yeast. Vaccines produced using this approach allow large scale production and hence greater availability for immunisation, e.g., hepatitis B vaccine producced from yeast.


Discussion

No Comment Found

Related InterviewSolutions